Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction

by Ayman Ibrahim, Ramadan Ghaleb, Hossam Mansour, Amr Hanafy, Naggeh M. Mahmoud, Mohamed Abdelfatah Elsharef, Mohamed Kamal Salama, Saud M. Elsaughier, Lobna Abdel-Wahid, Mona Embarek Mohamed, Ahmed K. Ibrahim, Ahmed Abdel-Galeel
Published 2020-12-01